Member of Pituitary Tumor Subgroup, Neuro-Oncology Professional Committee, Chinese Anti-Cancer Association
Council member of Tianjin Perioperative Medicine Research Association
Member, Head and Neck Neuro-Oncology Committee, Tianjin Medical Association
Dr. Ma specializes in minimally invasive endoscopic and microsurgical treatment of brain tumors and complex skull base lesions. His principal areas of expertise include:
Endoscopic endonasal and minimally invasive skull base surgery: surgical intervention for pituitary tumors, craniopharyngiomas, chordomas, meningiomas, schwannomas (including vestibular and trigeminal schwannomas), cholesteatomas, and tumors of the cranio-nasal and cranio-orbital regions.
Precision microsurgery for intracranial tumors: minimally invasive microsurgical treatment of gliomas, meningiomas, brain metastases, and other intracranial tumors.
Hydrocephalus and cranial reconstruction: various cerebrospinal fluid shunting procedures and cranioplasty.
Skull base reconstruction: surgical repair of cerebrospinal fluid rhinorrhea and surgical intervention for meningoencephaloceles.
Cranial nerve surgery: microvascular decompression for hemifacial spasm and repair and reconstruction of the facial and auditory nerves.
Complex skull base surgery: Minimally invasive surgical management of challenging skull base lesions.
Dr. Ma has undertaken advanced international training in endoscopic, minimally invasive, and skull base neurosurgery. He served as a visiting scholar at NewYork-Presbyterian Hospital, the Center for Cranial Base Surgery of the University of Pittsburgh, and the Department of Neurosurgery, Stanford University, USA.
After returning to China, he pioneered the introduction and development of minimally invasive neuroendoscopic surgical techniques. He has performed thousands of minimally invasive procedures for various types of brain tumors and is among the highest-volume brain tumor surgeons at Tianjin City Huanhu Hospital. He has extensive experience in the surgical treatment of pituitary tumors and craniopharyngiomas, including complex and challenging cases. His total resection outcomes for giant invasive pituitary tumors have reached the advanced domestic level, while endocrine remission rates for functioning pituitary tumors, including growth hormone-secreting pituitary adenomas causing acromegaly and ACTH-secreting pituitary adenomas causing Cushing’s disease, have reached internationally advanced levels.
In research, Dr. Ma has led or participated in numerous provincial- and municipal-level research projects, including key scientific research project of Tianjin’s health system. He is a recipient of the First-Class Tianjin Science and Technology Progress Award. He has also co-authored two specialist monographs, contributed to the translation of two additional monographs, and published multiple papers in domestic and international academic journals.